Medicine
Nereus 85 mg capsule
Nereus 85 mg capsule is a prescription medicine containing Tradipitant for oral use, marketed by Vanda Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store NEREUS capsules at controlled room temperature, 25°C (77°F), excursions…
Key facts
- Active ingredient (INN)
- Tradipitant
- Brand
- Nereus
- Strength
- 85 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 60 cartons, 36 cartons, 2 blister pack
- Marketing authorisation holder
- Vanda Pharmaceuticals
- Manufacturer
- Vanda Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store NEREUS capsules at controlled room temperature, 25°C (77°F), excursions permitted to 15°C to 30°C (59° - 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 March 2026
- Identifiers
- RxCUI 2739511, 2739517DailyMed set ID 1a021ebd-16ac-4354-b4b2-1c3950c091e5NDC 43068-585Application NDA220152
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 carton in 1 bottle / 1 capsule in 1 carton | 43068-585-01 | Vanda Pharmaceuticals | 31 March 2026 |
| 36 carton in 1 bottle / 1 capsule in 1 carton | 43068-585-02 | Vanda Pharmaceuticals | 31 March 2026 |
| 2 blister pack in 1 kit / 1 capsule in 1 blister pack | 43068-585-03 | Vanda Pharmaceuticals | 31 March 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 December 2025 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Tradipitant is a prescription medicine indicated for the prevention of vomiting induced by motion in adults. It is available as capsules for oral use. MedsAcross supplies Tradipitant for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TradipitantFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- NEREUS prescribing information (Vanda Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Nereus 85 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.